Pharmacokinetic and Pharmacodynamic Considerations for the Use of Monoclonal Antibodies in the Treatment of Bacterial Infections

Antibiotic-resistant bacterial pathogens are increasingly implicated in hospital- and community-acquired infections. Recent advances in monoclonal antibody (mAb) production and engineering have led to renewed interest in the development of antibody-based therapies for treatment of drug-resistant bac...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang-Lin, Shun Xin, Balthasar, Joseph P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6698815/
https://www.ncbi.nlm.nih.gov/pubmed/31544858
http://dx.doi.org/10.3390/antib7010005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6698815/
https://www.ncbi.nlm.nih.gov/pubmed/31544858
http://dx.doi.org/10.3390/antib7010005

Ejemplares similares